Loading...
Loading...
-converted.webp&w=3840&q=75)

Living with fibromyalgia can be deeply challenging. Pain may be constant or unpredictable. Fatigue can make even simple daily tasks feel difficult. Poor sleep, stiffness, brain fog, and flare-ups can affect every part of life — from work and family life to confidence, movement, and emotional well-being.
Many people living with fibromyalgia have spent a long time searching for answers. Some have tried multiple treatments with limited success. Others feel frustrated that their symptoms are not always fully understood.
At Skyline Hospitals, we understand that fibromyalgia is not simply about pain. It is a complex long-term condition that affects every person differently. That is why our approach is thoughtful, personal, and led by experienced specialists who take time to listen carefully. We look not only at your symptoms, but at the wider impact those symptoms are having on your life.
Fibromyalgia is increasingly understood as a condition involving altered pain processing within the nervous system. In simple terms, the body’s pain pathways can become over-sensitive, causing the brain and nerves to amplify pain signals. This is one reason why treatment often needs to go beyond standard pain relief alone. Our role is to help you understand your condition more clearly and guide you towards the most appropriate next steps.
A key part of our service is access to specialist intravenous lignocaine infusion therapy for carefully selected patients. This advanced treatment is delivered by Dr Arasu Rayen, Senior Consultant in Pain Management, as part of a broader personalised care plan for people whose pain remains difficult despite standard treatments.
In addition to specialist pain management, Skyline Hospitals also offers X-ray and ultrasound-guided joint injections at an affordable cost, giving patients access to precise, image-guided treatment for a range of musculoskeletal and joint-related pain conditions.
At Skyline Hospitals, we recognise that no two patients experience fibromyalgia in exactly the same way. That is why we focus on creating a treatment plan that is tailored to you, your symptoms, and your goals.
Patients often come to Skyline Hospitals because they want more than a brief appointment or a one-size-fits-all answer. They want to feel listened to, understood, and guided by an experienced specialist who recognises how much chronic pain can affect everyday life.
What makes our service different is the combination of compassionate consultant-led care with access to advanced lignocaine infusion treatment for appropriate patients. This gives selected patients the opportunity to explore a more specialist option within a carefully managed and personalised treatment pathway. Alongside this, Skyline Hospitals also provides X-ray and ultrasound-guided joint injections at affordable cost, offering accessible image-guided treatments for patients with joint pain, inflammation, and musculoskeletal conditions.
Skyline Hospitals brings together expert assessment, advanced pain treatment options, and a warm, personal approach to care. Our focus is not simply on managing symptoms in the short term, but on helping patients feel better supported, better informed, and more confident about the path ahead.

Every patient’s journey is individual, but our approach is always careful, supportive, and clinically led.
For some people with fibromyalgia, pain becomes deeply persistent and difficult to improve, even after trying medication, pacing, physiotherapy, and other supportive measures. In selected cases, intravenous lignocaine infusion therapy may be considered as part of a more specialist pain management plan.
Lignocaine is a medicine that has long been used as a local anaesthetic and in other medical settings, but in pain medicine it is valued for its wider effects on the way pain signals are processed by the nervous system. One of its key actions is on sodium channels, which are involved in the transmission of nerve impulses. When pain pathways become overactive or sensitised, these signals can fire more easily and more frequently than they should. Lignocaine is thought to help stabilise these nerve membranes and reduce abnormal electrical activity, which may lessen the intensity of pain signalling.
This is particularly relevant in fibromyalgia, where symptoms are increasingly linked to central sensitisation. In simple terms, this means the nervous system becomes unusually sensitive, so normal sensations may feel painful and painful sensations may feel amplified. This helps explain why fibromyalgia pain is often widespread, persistent, and difficult to tie to a single area of tissue damage or inflammation. Intravenous lignocaine may also influence the way pain signals are modulated within the spinal cord and brain, helping to reduce the overall “volume” of pain being processed by the body. In selected patients, this may lead to improvement not only in pain intensity, but sometimes also in pain sensitivity, flare severity, and the wider burden of chronic pain.
At Skyline Hospitals, this treatment is delivered by Dr Arasu Rayen, Senior Consultant in Pain Management, for carefully selected patients as part of a wider personalised care pathway. It is not a routine treatment for every patient with fibromyalgia, but it can be an important specialist option where symptoms remain severe, persistent, and life-limiting despite more conventional treatment.
Fibromyalgia is now widely understood as more than a muscle or joint problem alone. Many specialists believe that the condition involves changes in the way the nervous system processes pain, often referred to as central sensitisation. This means the body can become unusually sensitive, causing pain signals to be amplified and symptoms to feel more widespread and persistent.
Lignocaine infusion is thought to work by helping reduce abnormal nerve activity and calm sensitised pain pathways. In selected patients, this may help reduce pain intensity, sensitivity, and the severity of flare-ups. While it is not the right option for everyone, it can offer an important additional treatment pathway in complex cases.
Not every patient needs the same treatment. Alongside lignocaine infusion, Skyline Hospitals also offers X-ray and ultrasound-guided joint injections at affordable cost, allowing precise treatment for a range of joint, soft tissue, and musculoskeletal pain problems.
Living with fibromyalgia can be exhausting, frustrating, and at times isolating. We believe care should feel supportive and personal, with time taken to understand not only your symptoms, but also how they affect your life.
For selected patients whose symptoms remain difficult despite standard treatment, intravenous lignocaine infusion may provide access to a more specialist option within a carefully managed pain pathway.
Skyline Hospitals also offers X-ray and ultrasound-guided joint injections, helping patients access accurate, targeted treatment for a wide range of musculoskeletal and joint-related pain conditions.
At Skyline Hospitals, we aim to offer specialist pain treatments at transparent and accessible prices.
Lignocaine infusion for fibromyalgia and chronic pain — £995
Facet joint injections
Available for the shoulder, elbow, wrist, hand, hip, knee, ankle, and foot.
Image guidance
If X-ray or ultrasound guidance is required, please add £195.
Please note: consultation and follow-up fees may apply separately unless otherwise stated.
Fibromyalgia is a long-term condition that can cause widespread pain, fatigue, poor sleep, tenderness, and difficulty concentrating. It can affect every person differently and often has a significant impact on daily life.

If you are living with fibromyalgia, chronic pain, deep fatigue, or ongoing flare-ups, you do not have to navigate it alone. At Skyline Hospitals, we offer compassionate, specialist-led care designed to help you feel heard, supported, and better understood.
Book a consultation with Skyline Hospitals and take the next step towards understanding your symptoms and finding a more tailored path forward.